Tumor Volume Reduction Rate Predicts Pathologic Tumor Response of Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemotherapy alone: Results from a Prospective Trial

Jian Xiao(Sun Yat-sen University), Jianping Wang(Shanghai Micro Satellite Engineering Center), Donglin Ren(Sun Yat-sen University), Wenyun Li(National University of Singapore), Junsheng Peng(Guangzhou University of Chinese Medicine), Zuli Yang(Sun Yat-sen University), Lei Wang(Sun Yat-sen University), Xiaojian Wu(Guangxi Academy of Agricultural Science), Zerong Cai(Sun Yat-sen University), Yan Huang(Shanghai Pulmonary Hospital), Jiaying Gong(Sun Yat-sen University), Ping Lan(Sun Yat-sen University), Yanhong Deng(Sun Yat-sen University)
Journal of Cancer
January 1, 2015
10.7150/jca.11738
Cited by 31

Related Papers

Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA
|Clinical Cancer Research|2018|456
A LaCl3-based lithium superionic conductor compatible with lithium metal
|Nature|2023|451
Effect of Fruquintinib vs Placebo on Overall Survival in Patients With Previously Treated Metastatic Colorectal Cancer
|JAMA|2018|410
Neoadjuvant Modified FOLFOX6 With or Without Radiation Versus Fluorouracil Plus Radiation for Locally Advanced Rectal Cancer: Final Results of the Chinese FOWARC Trial
|Journal of Clinical Oncology|2019|410
Modified FOLFOX6 With or Without Radiation Versus Fluorouracil and Leucovorin With Radiation in Neoadjuvant Treatment of Locally Advanced Rectal Cancer: Initial Results of the Chinese FOWARC Multicenter, Open-Label, Randomized Three-Arm Phase III Trial
|Journal of Clinical Oncology|2016|409